Oñate G, Bataller A, Garrido A, et al; CETLAM (Spanish Cooperative Group for the Diagnosis and Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Adv. 2022;6(3):882-890
- PMID: 36917130
- PMCID: PMC10037083
- DOI: 10.1182/bloodadvances.2022009604
Oñate G, Bataller A, Garrido A, et al; CETLAM (Spanish Cooperative Group for the Diagnosis and Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes). Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1. Blood Adv. 2022;6(3):882-890
Erratum for
-
Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1.Blood Adv. 2022 Feb 8;6(3):882-890. doi: 10.1182/bloodadvances.2020004136. Blood Adv. 2022. PMID: 34516636 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
